Video není dostupné.
Omlouváme se.

Survaxm Vaccine For Glioblastoma

Sdílet
Vložit
  • čas přidán 17. 07. 2023
  • Presented as part of the Musella Foundations' Brain Tumor Webinar Series.
    Speaker: Michael Ciesielski, PhD, Chief Executive Officer of MimiVax, LLC
    Presented on 7/18/23

Komentáře • 6

  • @danielregufe
    @danielregufe Před 10 měsíci

    Hello. Is there any expectation of testing this vaccine in Brazil?

  • @pw2563
    @pw2563 Před 8 měsíci

    Can this be used just after a patient starts using Optune or is it limited to patients who just completed radiation? How does someone get accepted to clinical trial?

  • @MohaMoha-dq5qj
    @MohaMoha-dq5qj Před 6 měsíci

    Hi and thanks for informative presentation. I have gbm that was diagnosed in February 2023. I had surgery followed by radiation and temozolomide for 40 days. I had a good recovery. From July to December 23 i had chemo temozolimide higher doze. But, in decemer 23 i had an mri that a recurrence and doctor prescribed avastin and irinotecan for six sessions each taken every two weeks. Tolerance has been relevatly good.
    My query is whether is it possible to participate in the these clinical trials after current avastin/ irinotecan?

    • @musellafoundation
      @musellafoundation  Před 6 měsíci +1

      Contact the clinical trial center closed to you and ask. If they say no, ask about expanded access.

  • @jamesbelvin1271
    @jamesbelvin1271 Před 11 měsíci

    So what is the current progress with this therapy? Does it work?

    • @musellafoundation
      @musellafoundation  Před 11 měsíci +1

      It looks like it works. It is in the final stages of trials before it can apply for fda approval